Neuroscience News and Research

RSS

FAU neuroscientist develops Quick Dementia Rating System comparable to gold standard clinical tests

Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.

13 Aug 2015

Researchers identify novel brain network that plays wide role in memory and learning processes

One of the more heartbreaking realities of Alzheimer's is the moment when a loved one struggling with the disease no longer fully recognizes a family member or close friend who is caring for them.

13 Aug 2015

Regular exercise benefits children with multiple sclerosis

A new study suggests children with multiple sclerosis (MS) who exercise regularly may have a less active disease. The research is published in the August 12, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

13 Aug 2015

Dartmouth researcher finds way to predict human emotions

A Dartmouth researcher and his colleagues have discovered a way to predict human emotions based on brain activity.

12 Aug 2015

Ion channel blockers prove useful in cancer therapy

Drugs called ion channel blockers, which are commonly used to treat cardiac, neurological, and psychiatric disorders, might prove useful in cancer therapy, according to research findings in fruit flies and mice by UC San Francisco scientists that led to unconventional treatment of a case of metastatic brain cancer.

12 Aug 2015

Study sheds light on what motivates people to trust

Trust matters whether it's love, money or another part of our everyday lives that requires risk, and a new study by a Dartmouth brain researcher and his collaborators sheds light on what motivates people to make that leap of faith.

12 Aug 2015

Loss of critical receptor in the brain may be responsible for autism, schizophrenia

The loss of a critical receptor in a special class of inhibitory neurons in the brain may be responsible for neurodevelopmental disorders including autism and schizophrenia, according to new research by Salk scientists.

12 Aug 2015

New project examines links between language and perception in people with ASD

How do children and young adults with autism spectrum disorders (ASD) understand idioms and other figures of speech? A 4.15 million euro EU project based out of the Norwegian University of Science and Technology is examining the links between language and perception in autistic individuals as just one of 15 cross-disciplinary projects designed to bring a better understanding to how our perception and language interact and change over time and in individuals.

11 Aug 2015

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) announced today the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for review to add clinical data regarding the effect of Brintellix (vortioxetine) on certain aspects of cognitive function in adults with Major Depressive Disorder (MDD) to the current product label.

11 Aug 2015

Researchers report role of two gene-regulating molecules in Parkinson's disease

As Parkinson's disease progresses in patients, a puzzling dichotomy plays out in their brains. One set of neurons degenerates, while a similar population nearby is spared the same degree of damage. Why the difference? An answer to this question could clear the way for preventions and treatments for this disease, which impairs movement.

11 Aug 2015

DISC-1: schizophrenia's "Rosetta Stone" gene? An interview with Professor Kevin Fox

The DISC-1 gene has been studied intensively over the years because people with mutations in DISC1 have a high likelihood of mental illness. DISC-1 was known to be associated with schizophrenia, bipolar disorder, major clinical depression and autism.

10 Aug 2015

Roche establishes strategic alliance with Diagnostic Laboratory Services

Roche announced today the establishment of a strategic alliance with Diagnostic Laboratory Services of Aiea, Hawaii, that designates the company as a Roche Molecular Center of Excellence (MCOE) for the next five years.

From Roche Sequencing and Life Science 10 Aug 2015

BMC partners with RIH, CVS to support pharmacy-based naloxone rescue kits to help combat opioid addiction, overdose

Boston Medical Center has received a $1.3 million grant from the Agency for Healthcare Research and Quality to support a demonstration project of pharmacy-based naloxone rescue kits to help reduce opioid addiction and overdose death in two New England States: Massachusetts and Rhode Island.

7 Aug 2015

UNC researchers show how a genetic mutation disables molecular switch and causes autism

Last December, researchers identified more than 1,000 gene mutations in individuals with autism, but how these mutations increased risk for autism was unclear. Now, UNC School of Medicine researchers are the first to show how one of these mutations disables a molecular switch in one of these genes and causes autism.

7 Aug 2015

Einstein and Montefiore researchers receive $1.2 million grant to advance spinal cord injury research

Researchers at Albert Einstein College of Medicine and Montefiore Health System have received a $1.2 million grant from New York State to advance their promising technology for treating paralysis and other effects of spinal cord injuries (SCI).

7 Aug 2015

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.

6 Aug 2015

Scientists use highly specialized X-ray crystallography technique to solve protein structure of HIFs

In a collaborative study between Sanford Burnham Prebys Medical Discovery Institute and the Argonne National Laboratory, scientists have used a highly specialized X-ray crystallography technique to solve the protein structure of hypoxia-inducible factors (HIFs), important regulators of a tumor's response to low oxygen (hyopoxia).

6 Aug 2015

New research could help understand how ongoing behavior influences visual perception

Our brains are constantly barraged with sensory information, but have an amazing ability to filter out just what they need to understand what's going on around us. For instance, if you stand perfectly still in a room, and that room rotates around you, it's terrifying.

5 Aug 2015

Sleeping in lateral position may effectively remove brain waste, say Stony Brook researchers

Sleeping in the lateral, or side position, as compared to sleeping on one's back or stomach, may more effectively remove brain waste and prove to be an important practice to help reduce the chances of developing Alzheimer's, Parkinson's and other neurological diseases, according to researchers at Stony Brook University.

5 Aug 2015

Brain's electrical activity may be more primary factor in memory solidification

The permanence of memories has long thought to be mediated solely by the production of new proteins. However, new research from the University of Alberta has shown that the electrical activity of the brain may be a more primary factor in memory solidification.

5 Aug 2015

Neuroscience News and Research

FAU neuroscientist develops Quick Dementia Rating System comparable to gold standard clinical tests

Researchers identify novel brain network that plays wide role in memory and learning processes

Regular exercise benefits children with multiple sclerosis

Dartmouth researcher finds way to predict human emotions

Ion channel blockers prove useful in cancer therapy

Study sheds light on what motivates people to trust

Loss of critical receptor in the brain may be responsible for autism, schizophrenia

New project examines links between language and perception in people with ASD

FDA accepts sNDA to review Brintellix clinical trial data for treatment of major depressive disorder

Researchers report role of two gene-regulating molecules in Parkinson's disease

DISC-1: schizophrenia's "Rosetta Stone" gene? An interview with Professor Kevin Fox

Roche establishes strategic alliance with Diagnostic Laboratory Services

BMC partners with RIH, CVS to support pharmacy-based naloxone rescue kits to help combat opioid addiction, overdose

UNC researchers show how a genetic mutation disables molecular switch and causes autism

Einstein and Montefiore researchers receive $1.2 million grant to advance spinal cord injury research

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

Scientists use highly specialized X-ray crystallography technique to solve protein structure of HIFs

New research could help understand how ongoing behavior influences visual perception

Sleeping in lateral position may effectively remove brain waste, say Stony Brook researchers

Brain's electrical activity may be more primary factor in memory solidification

Neuroscience - Third Edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News